Portugal, May 19 -- Portugal based FRESENIUS KABI PHARMA PORTUGAL has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Invitation To The Presentation Of Proposals Under The Agreement (S) - Framework 2023/304 - Group 4: Blood Medicines; 2023/491 - Cancer And Immunomodulators And 2023/492 - Medicine. The value of the contract is worth 1428897 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....